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Elevated primary melanoma-specific T cell responses in blood predict the development of vitiligo. (A) Schematic diagram of treatment schedule. 
(B–D) Mice were primed as shown in A and then monitored for depigmentation. (B) Depigmentation kinetics. Data represent 34 mice from 4 com-
bined experiments. (C) Progression of depigmentation. Photos show representative mice with disseminated or local patterns of depigmentation. 
Data represent 24 mice from 4 combined experiments. (D) Effect of anti-CD8 mAb administered 2 days before surgery and weekly thereafter. The 
experiment involved 10 mice/group and was conducted twice with similar results. Statistical significance was determined by log-rank analysis. 
(E) Mice received adoptive transfer of 104 naive CD8+Thy1.1+ pmel cells 1 day before treatment as in A. Flow cytometry was performed to cor-
relate pmel populations, in blood, on the day of surgery, with the eventual development of vitiligo (open squares) or lack thereof (filled squares) 
on day 30. Top: Proportion of Thy1.1+ pmel cells among CD8+ cells. Bottom: Proportion of activated CD44hiCD62Llo cells among CD8+Thy1.1+ 
pmel cells (phenotype data are provided only for mice with more than 50 pmel events). Symbols represent individual mice, and horizontal lines 
represent averages. Data represent 3 combined experiments. Statistical significance was determined by t test.
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Hosts with vitiligo develop larger populations of melanoma antigen–spe-

























Vitiligo-affected hosts develop larger CD8+ TEM cell responses compared with unaffected hosts. (A) Mice were treated as in Figure 1A. Sixty 
days after surgery, IFN-γ ELISPOT was performed on CD8+ T cells from vitiligo-affected or unaffected mice (pooled, 6 mice/group), with peptide-
pulsed EL4 cells as targets. Data represent average ± SD of 4 replicate wells. Irrel, irrelevant peptide. (B–D) Mice received 104 naive pmel cells 
1 day prior to treatment as in Figure 1A. Thirty days after surgery, flow cytometry was performed to detect differences between unaffected and 
vitiligo-affected mice with regard to (B) the proportion of pmel cells among CD8+ cells and (C) the proportion of CD8+Thy1.1+CD44hi pmel cells 
with a CD62Llo TEM phenotype. (D) Ninety-days after surgery, the proportion of pmel cells in lymph nodes that produced cytokines upon peptide 
restimulation. (E and F) Mice received 104 naive Ly5.2+ OT-1 cells 1 day prior to treatment as in Figure 1A, but received B16-OVA tumors. 
The proportion of OT-1 cells among CD8+ cells 30 days after surgery (E) and the proportion of OT-1 cells with a CD62Lhi TCM phenotype 36 
days after surgery (F) were determined. In B–F, flow cytometry plots depict data from representative mice, symbols represent individual mice, 
and horizontal lines represent averages. Differences between vitiligo-affected and unaffected groups were assessed by t test, with *P < 0.05, 
**P < 0.01, and ***P < 0.001 and NS denoting P > 0.05. Differences between relevant and irrelevant peptide were significant unless indicated. 
Each experiment was performed at least twice, with similar results.
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Melanocyte-deficient mice do not develop robust effector memory T cell responses following melanoma excision. (A–D) Wild-type or Wsh mice 
received 104 naive Thy1.1+ pmel cells 1 day prior to treatment as in Figure 1A. (A) B16 tumor growth. (B) On the day of surgery, compari-
son between wild-type and Wsh mice with regard to the proportion of Thy1.1+ pmel cells among total CD8+ T cells in blood, and phenotype of 
CD8+Thy1.1+ pmel cells in lymph nodes. (C and D) Sixty days after surgery, comparison between wild-type unaffected, wild-type vitiligo-affected, 
and Wsh mice with regard to (C) the proportion of Thy1.1+CD44+ pmel cells among total CD8+ T cells and (D) the proportion of CD8+ Thy1.1+CD44hi 
pmel cells with a CD62Lhi TCM phenotype. Data are combined from 2 identical experiments. (E and F) Mice received 104 naive Ly5.2+ OT-1 cells 
1 day prior to treatment as in Figure 1A, but received B16-OVA tumors. Thirty days after surgery, (E) the proportion of Ly5.2+ OT-1 cells among 
total CD8+ cells and (F) the proportion of CD8+Ly5.2+CD44hi OT-1 cells with a CD62Lhi TCM phenotype was determined. Flow cytometry plots depict 
data from representative mice, symbols represent individual mice, and horizontal lines represent averages. Statistically significant differences were 
assessed by t test, with *P < 0.05, **P < 0.01, ***P < 0.001. Each experiment was performed at least twice, with similar results.
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Restoration of melanocyte antigen to T cells primed in Wsh mice rescues robust effector memory T cell populations. Wsh mice received 104 naive 
Thy1.1+ pmel cells 1 day before treatment as in Figure 1A. (A and B) Starting on the day of surgery, mice received 40 μg of mouse gp100–
expressing plasmid, or empty vector control i.m., once weekly for 30 days. Thirty days after surgery, (A) the proportion of pmel cells among total 
CD8+ cells in each organ and (B) expression of CD62L on CD8+ pmel or host CD44hi cells were determined by flow cytometry. Histogram depicts 
data from 1 representative gp100-treated mouse; fewer than 50 pmel events were obtained for 7 of 8 mice treated with empty vector. (C and 
D) Total CD8+ cells were harvested from inguinal lymph nodes and spleens of Wsh mice on day 12 and adoptively transferred into the indicated 
recipients that had been pretreated as in Figure 1A. Thirty days after surgery/adoptive transfer, recipients were analyzed for (C) proportion of 
pmel cells among total CD8+ cells and (D) CD62L expression on CD8+ pmel or host CD44hi cells in inguinal lymph nodes. Histogram depicts data 
from 1 representative vitiligo recipient; fewer than 50 pmel events were obtained for each of the Wsh recipients. Dot plots in A and C depict data 
from representative mice. Data represent 2 combined experiments with similar results; symbols represent individual mice, and horizontal lines 
represent averages. Statistically significant differences were assessed by t test.
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Melanoma-specific memory T cells are maintained in vitiligo-affected mice despite hyporesponsiveness to homeostatic cytokines. (A–C) Mice 
were treated as in Figure 1A. (A) 260 days after surgery, IFN-γ ELISPOT was performed on CD8+ T cells from pooled lymph nodes (5–8 mice/
group), with peptide-pulsed EL4 cells as targets. Vitiligo was classified as described in Figure 1. Data represent average ± SD of 4 replicate wells. 
(B–D) Mice received 104 naive Thy1.1+ pmel cells 1 day prior to treatment as in Figure 1A. Symbols represent individual mice, and horizontal 
lines represent averages. (B) At various times following surgery, the proportion of pmel (Thy1.1+) cells among total CD8+ T cells in lymph nodes 
was assessed by flow cytometry. Data from unaffected and vitiligo-affected mice were statistically different (P < 0.05 by t test) at all time points 
except day 90. (C) 215 days following surgery, CD8+Thy1.1+CD44hi pmel cells were assessed for expression of phenotypic markers. Histograms 
depict data from representative lymph node samples. (D) Thirty days after surgery, CD8+ T cells were isolated from spleens of vitiligo-affected 
mice and cultured with IL-15 or IL-7, and the proportion of Thy1.1+CD44hi pmel cells undergoing at least 1 round of division (% Proliferated) 
was assessed by CFSE dilution. Host memory phenotype T cells (CD8+CD44hiThy1.1–) were analyzed as a positive control. Symbols repre-
sent single wells; the experiment was performed 3 times, with similar results. Statistically significant differences were assessed by t test, with 
*P < 0.05, **P < 0.01, and ***P < 0.001.
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Melanoma-specific memory T cells are maintained for many months 






































Vitiligo-associated memory T cells mount a rapid recall response and pro-
vide protection upon melanoma re-challenge. The above experiments 
demonstrated that melanocyte destruction drives  robust and 
Figure 6
Protective post-surgical memory is only maintained in hosts with vitiligo. Mice were either primed as shown in Figure 1A or left untreated, strati-
fied based on the development or lack of vitiligo 30–60 days later, and rechallenged with B16 melanoma. (A) Incidence of tumors inoculated i.d., 
30 days after surgery. Anti-CD8 was administered 2 days prior to challenge and weekly thereafter. Data represent 6–22 mice/group, combined 
from 2 experiments. (B) Incidence of tumors inoculated i.v., 30 days after surgery. Lung tumor burden was assessed 21 days after challenge; 
symbols represent individual mice. (C) Incidence of tumors inoculated i.d., 60 days after surgery. Data represent 19–25 mice/group, combined 
from 3 experiments. (D and E) Mice received i.d. tumor challenge 30 days after surgery, and recall responses were assessed in draining lymph 
nodes 6 days later. (D) IFN-γ ELISPOT was performed on CD8+ T cells from pooled lymph nodes (6 mice/group), with peptide-pulsed EL4 cells 
or B16 cells as targets. Data represent mean ± SD of 4 replicate wells. (E) Mice received 104 Thy1.1+ pmel cells 1 day before priming, and the 
proportion of Thy1.1+ pmel cells among total CD8+ T cells was assessed by flow cytometry. Symbols represent individual mice, and horizontal 
lines represent averages. Data are combined from 2 experiments. Significance was determined by log-rank analysis (A and C) or t test (B, D, 
and E), with **P < 0.01, ***P < 0.001, and NS denoting P > 0.05. 3X and 10X indicate 3-fold and 10-fold increases, respectively.
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Long-lived effector memory T cells in hosts with vitiligo do not become func-
tionally or phenotypically exhausted. Hosts with vitiligo clearly main-
tained protective populations of memory CD8+ T cells. However, 
Figure 7
Memory T cells do not become functionally or phenotypically exhausted after many months of exposure to vitiligo. Mice received 104 naive 
Thy1.1+ pmel cells 1 day prior to treatment as outlined in Figure 1A. (A) 150 days after surgery, the proportion of CD8+Thy1.1+CD44hi pmel cells in 
lymph nodes that produced cytokine upon peptide restimulation was determined by flow cytometry. Squares represent individual vitiligo-affected 
mice. (B) 300 days after surgery, expression of phenotypic markers on CD8+Thy1.1+CD44hi pmel cells from vitiligo-affected mice was assessed. 
Host TEM or TCM indicates CD8+CD44hi cells from the same mouse that were CD62Llo or CD62Lhi, respectively. Activated control (arrows and 
dotted lines) refers to pmel cells that were cultured in vitro with PHA for 3 days. Histograms depict data from representative lymph node samples; 
triangles represent individual mice; and horizontal lines represent averages. (C) 600 days after surgery, PD-1 expression on CD8+Thy1.1+ pmel 
cells in lymph nodes of vitiligo-affected mice was assessed. Histograms depict lymph node sample of a single mouse (representative of 3 mice). 
Statistical significance was determined by ANOVA, with *P < 0.05, **P < 0.01, and ***P < 0.001. An identical phenotypic analysis was conducted 
on day 60 after surgery, with similar results (data not shown).
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Model depicting the generation of vitiligo and its ongoing influence on T cell memory to melanoma. 
Naive CD8+ T cells are primed in response to melanoma growth in the absence of CD4+ Tregs. Top: 
Primary T cell responses that overcome a threshold (indicated by the dashed line) are robust enough 
to initiate the development of vitiligo. Ongoing melanocyte destruction in these hosts subsequently 
boosts and perpetuates a vigorous, protective TEM population. Bottom: Primary T cell responses below 
this threshold do not initiate vitiligo. The absence of melanocyte destruction in these hosts results in a 
small TCM population that does not confer tumor protection.
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In vitro IL-15 and IL-7 proliferation assay. Thirty days after surgical tumor 
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